CytoCares Inc
2 clinical trials · 2 recruiting · INDUSTRY
Trials by CytoCares Inc
RECRUITINGPhase 1NCT07177911
Safety and Efficacy Study of CC312 for Moderate to Severe SLE
This study is a randomized, double-blind, placebo-controlled Phase I clinical trial featuring single and multiple ascending doses. It is designed to evaluate the safety,...
Sponsor: CytoCares IncEnrolling: 321 location
SLE - Systemic Lupus Erythematosus
RECRUITINGEarly Phase 1NCT06888960
Safety Study of CC312 in Autoimmune Disease Patients
This study is an open-label, multiple-dose escalation, Investigator-Initiated Trial (IIT) clinical trial designed to evaluate the safety and tolerability of CC312 in adult...
Sponsor: CytoCares IncEnrolling: 181 location
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+3